| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_881161e8b136eb3e536eca2a234239fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
1999-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db51ded90e98642e97b9139f8fe3ef3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c11f288543789c520c15ebc550b7e57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20719ab86f5a9e1f01b169caf44b8522 |
| publicationDate |
2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-513051-A |
| titleOfInvention |
Transdermal drug delivery system containing the skin penetration enhancers crotamiton or diethyltoluamide |
| abstract |
A method of preparing a transdermal drug delivery system comprises: a) dissolving a pharmaceutically active substance in a solvent comprising one or more skin penetration enhancers to form a solution of active substance in the skin penetration enhancers at a concentration less than saturation; b) mixing the resultant solution with an adhesive in the form of an aqueous solution or dispersion; c) forming the mixture obtained in step b) into a film on a release liner or backing sheet and d) drying the film at a temperature less than the boiling point of the skin penetration enhancer or enhancers used as solvents in the dissolution step a). The skin penetration enhancer can be crotamiton or diethyltoluamide. |
| priorityDate |
1998-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |